Inari Medical announced preliminary unaudited fourth quarter and full year 2022 revenue and provided estimates for its 2023 guidance. Preliminary unaudited revenue for the full year 2022 is expected to be between $382.7 million and $383.7 million, up approximately 38% over the full year 2021. Ended 2022 with over 275 U.S. sales territories.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NARI:
